Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-30 @ 2:54 PM
Study NCT ID:
NCT01178268
Status:
COMPLETED
Last Update Posted:
2016-08-24
First Post:
2010-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'removedCountries': ['United States']}, 'conditionBrowseModule': {'meshes': [{'id': 'D054059', 'term': 'Coronary Occlusion'}, {'id': 'D013927', 'term': 'Thrombosis'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D017202', 'term': 'Myocardial Ischemia'}, {'id': 'D023921', 'term': 'Coronary Stenosis'}, {'id': 'D003327', 'term': 'Coronary Disease'}, {'id': 'D003324', 'term': 'Coronary Artery Disease'}, {'id': 'D023903', 'term': 'Coronary Restenosis'}], 'ancestors': [{'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D016769', 'term': 'Embolism and Thrombosis'}, {'id': 'D001161', 'term': 'Arteriosclerosis'}, {'id': 'D001157', 'term': 'Arterial Occlusive Diseases'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'dana.haudek@av.abbott.com', 'phone': '928-925-4054', 'title': 'Dana Haudek', 'organization': 'Abbott Vascular'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'timeFrame': '2 Years', 'eventGroups': [{'id': 'EG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.', 'otherNumAtRisk': 360, 'otherNumAffected': 32, 'seriousNumAtRisk': 360, 'seriousNumAffected': 53}, {'id': 'EG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.', 'otherNumAtRisk': 120, 'otherNumAffected': 14, 'seriousNumAtRisk': 120, 'seriousNumAffected': 24}], 'otherEvents': [{'term': 'Angina', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Chest Distress Because Of Air Pollution', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Chest Distress Occasionally', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Chest Pain Happens More Frequently', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Chest Tightness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Creatine kinase-MB (CK-MB0 Increase', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Coronary Artery Disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Cardiac troponin T increased (cTnI)', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Cardiac troponin T of Post-Procedure Increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Melena', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Myocardial infarction (MI)', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Peri-procedural PCI and MI', 'notes': 'Peri-procedural percutaneous coronary intervention (PCI) and peri-procedural myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Premature Beat', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'The Cardiac Enzyme Is Higher', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Abnormal troponin I (TnI)', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Troponin I (TnI) Increase', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 5, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Troponin I (TnI) Increase Significantly', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Troponin I (TnI) Of Post Procedure Increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Troponin T (TnT) of Post Procedure Increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Vessel Interlayer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Breathing Difficulty', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Complication of percutaneous coronary intervention (PCI) Procedure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Gastrorrhagia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Nasal Bleeding', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}], 'seriousEvents': [{'term': 'Angina', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 8, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Arrhythmia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Atrioventricular Block (AVB)', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Chest Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Creatine kinase MB (CK-MB) increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Coronary Artery Disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Coronary Dissection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Coronary Heart Disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Fibrillation Atrial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Gastric Ulcer With Bleeding', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Gastrointestinal Bleeding', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Hear Failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 3, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Melena', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Non-Targeted Vessel Revascularization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Restenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 4, 'numAffected': 3}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Revascularization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 9, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Subarachnoid Hemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Syncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Target Lesion Revascularization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Non-Target Vascular Stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Thrombocytopenic Purpura', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Respiratory Fail, Chronic Bronchitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Unstable Angina', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 5, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 3, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Upper Gastrointestinal Bleeding', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Vascular Stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Extrasystole; Fibrillation Atrial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 2, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Coronary heart disease (CHD), Coronary Revascularization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Liver Cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Paroxysmal Atrial Fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 3, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Target Vessel Revasculization', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}, {'term': 'Non-Target Vessel Restenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 360, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 120, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 10.0'}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'In-stent Late Loss (LL)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '279', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Lesions', 'counts': [{'value': '279', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.19', 'spread': '0.28', 'groupId': 'OG000'}, {'value': '0.21', 'spread': '0.28', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '>=13 months', 'description': 'This is the primary angiographic endpoint.\n\nIn-stent LL: The difference between the minimum lumen diameter (MLD) immediately after stent deployment and the MLD at follow-up (within stent)', 'unitOfMeasure': 'Millimeter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'PRIMARY', 'title': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.4', 'groupId': 'OG000', 'lowerLimit': '2.51', 'upperLimit': '6.98'}, {'value': '6.6', 'groupId': 'OG001', 'lowerLimit': '2.90', 'upperLimit': '12.61'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is the primary efficacy endpoint. Ischemia-driven target vessel failure is defined as the composite of cardiac death, all myocardial infarction (MI) and ischemia-driven target vessel revascularization (ID-TVR).', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'PRIMARY', 'title': 'Incidence of Composite of ST (Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.6', 'groupId': 'OG000', 'lowerLimit': '0.60', 'upperLimit': '3.52'}, {'value': '1.7', 'groupId': 'OG001', 'lowerLimit': '0.20', 'upperLimit': '5.84'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'The primary composite safety endpoint was the incidence of the composite of ST (definite and probable), all death (cardiac, vascular and non-cardiovascular), and all MI (including Q-wave and non-Q-wave).', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\]).', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '3.3', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.7', 'groupId': 'OG000'}, {'value': '7.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave).', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave).', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Revascularization (ID-TLR) (Percutaneous Coronary Intervention [PCI] and Coronary Artery Bypass Graft [CABG])', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000', 'lowerLimit': '0.77', 'upperLimit': '3.89'}, {'value': '3.3', 'groupId': 'OG001', 'lowerLimit': '0.91', 'upperLimit': '8.25'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'The is the major Secondary Efficacy Endpoint.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'Incidence of composite of cardiac death, MI attributed to the TV and ID-TLR', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'Incidence of composite of cardiac death, MI attributed to the TV and ID-TLR', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '2.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'This is one of the Secondary Composite Endpoints.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.5', 'groupId': 'OG000'}, {'value': '5.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is one of the Secondary Composite Endpoints.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.9', 'groupId': 'OG000'}, {'value': '5.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'This is one of the Secondary Composite Endpoints.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.6', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.7', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.6', 'groupId': 'OG000'}, {'value': '2.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.2', 'groupId': 'OG000'}, {'value': '5.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '6.3', 'groupId': 'OG000'}, {'value': '10.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '8.5', 'groupId': 'OG000'}, {'value': '11.6', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.6', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.4', 'groupId': 'OG000'}, {'value': '2.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.5', 'groupId': 'OG000'}, {'value': '5.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.9', 'groupId': 'OG000'}, {'value': '5.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Revascularization (TLR, TVR, and Non-TVR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.3', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 Days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Revascularization (TLR, TVR, and Non-TVR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.5', 'groupId': 'OG000'}, {'value': '1.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 Months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Revascularization (TLR, TVR, and Non-TVR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '3.3', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 Months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Revascularization (TLR, TVR, and Non-TVR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.6', 'groupId': 'OG000'}, {'value': '9.1', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Revascularization (TLR, TVR, and Non-TVR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '6.6', 'groupId': 'OG000'}, {'value': '9.9', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'One of the Secondary Safety Endpoint was all revascularization rates (target lesion, target vessel, non-target lesion, and non-target vessel) (PCI and CABG).', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.3', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.5', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.5', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Target Vessel Protocol MI (TV-MI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Target Vessel Protocol MI (TV-MI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Target Vessel Protocol MI (TV-MI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Target Vessel Protocol MI (TV-MI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Target Vessel Protocol MI (TV-MI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '363', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '0.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Bleeding Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'description': 'Secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Bleeding Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'description': 'Secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Bleeding Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '366', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'description': 'Secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Bleeding Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '365', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.5', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'description': 'Secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Major Bleeding Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '360', 'groupId': 'OG000'}, {'value': '120', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.8', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Secondary safety endpoint.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.27', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Acute (<1 day)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.27', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Subacute (1 - 30 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.54', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Early (0 - 30 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.00', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Late (31 - 365 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.00', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Very late (366 - 772 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Definite / Probable Stent Thrombosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.54', 'groupId': 'OG000'}, {'value': '0.00', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Overall (0 - 772 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '362', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '99.2', 'groupId': 'OG000'}, {'value': '99.2', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '30 days', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '362', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '99.2', 'groupId': 'OG000'}, {'value': '97.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '6 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '362', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '98.1', 'groupId': 'OG000'}, {'value': '95.9', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '9 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '362', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '94.5', 'groupId': 'OG000'}, {'value': '93.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '12 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '362', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '58.0', 'groupId': 'OG000'}, {'value': '55.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Acute Device Success', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '399', 'groupId': 'OG000'}, {'value': '129', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '97.2', 'groupId': 'OG000'}, {'value': '98.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '< or = 1 day', 'description': 'Per-protocol device success is defined as the achievement of a final in-stent residual diameter stenosis (DS) of \\< 50% by Quantitative Coronary Angiography (QCA), using only the assigned device, and occurring without a device malfunction.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants'}, {'type': 'SECONDARY', 'title': 'Acute Procedure Success', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '98.1', 'groupId': 'OG000'}, {'value': '99.2', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '< or = 1 day', 'description': 'Per-protocol procedure success is defined as the achievement of a final in-stent DS of \\< 50% (by online QCA or visual estimation), using the assigned device and with any adjunctive devices, and occurring without cardiac death, MI (including Q-wave or non-Q-wave), or repeat revascularization of the target lesion during the hospital stay.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Procedure Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '29.6', 'spread': '19.3', 'groupId': 'OG000'}, {'value': '28.6', 'spread': '15.8', 'groupId': 'OG001'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'On day 0, during the procedure.', 'description': 'This is the procedure related endpoint. Procedure time is defined as time between insertion of the first guiding catheter until removal of the last guiding catheter.', 'unitOfMeasure': 'Minutes', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Amount of Contrast Used', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '132.1', 'spread': '53.2', 'groupId': 'OG000'}, {'value': '145.4', 'spread': '59.2', 'groupId': 'OG001'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'On day 0, during the procedure.', 'description': 'Defined as total amount used from insertion of the first guiding catheter until removal of the last guiding catheter.', 'unitOfMeasure': 'Milliliter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Fluoroscopy Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '7.0', 'spread': '4.7', 'groupId': 'OG000'}, {'value': '7.4', 'spread': '4.7', 'groupId': 'OG001'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'On day 0, during the procedure.', 'description': 'This is the procedure related endpoint.', 'unitOfMeasure': 'Minutes', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'XIENCE V EECSS Excellent Overall Performance and Deliverability Using the XIENCE V EECSS Performance Evaluation Questionnaire', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '93.2', 'groupId': 'OG000'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'During the procedure', 'description': 'A related secondary performance goal for XIENCE V EECSS is the physician-determined evaluation of acute performance, deliverability, and resource utilization. XIENCE V EECSS acute performance and deliverability were determined using the XIENCE V EECSS Performance Evaluation Questionnaire. Possible responses included strongly agree,moderately agree, agree, moderately disagree, and strongly disagree. Study physicians who enrolled patients into the study were reported for this outcome measure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Follow-up Late Loss', 'denoms': [{'units': 'Participants', 'counts': [{'value': '279', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '279', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'title': 'In-Segment', 'categories': [{'measurements': [{'value': '0.15', 'spread': '0.35', 'groupId': 'OG000'}, {'value': '0.27', 'spread': '0.35', 'groupId': 'OG001'}]}]}, {'title': 'Proximal', 'categories': [{'measurements': [{'value': '0.20', 'spread': '0.34', 'groupId': 'OG000'}, {'value': '0.33', 'spread': '0.39', 'groupId': 'OG001'}]}]}, {'title': 'Distal', 'categories': [{'measurements': [{'value': '0.11', 'spread': '0.32', 'groupId': 'OG000'}, {'value': '0.20', 'spread': '0.33', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '≥13 months.', 'description': 'This is one of the Secondary Angiographic Endpoint.', 'unitOfMeasure': 'Millimeter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-stent Minimum Lumen Diameter (MLD)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.62', 'spread': '0.50', 'groupId': 'OG000'}, {'value': '2.63', 'spread': '0.48', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '≥13 months', 'unitOfMeasure': 'Millimeter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-stent Percent Diameter Stenosis (DS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '10.56', 'spread': '10.18', 'groupId': 'OG000'}, {'value': '11.82', 'spread': '10.30', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '≥13 months', 'unitOfMeasure': 'percent Diameter stenosis', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-stent Angiographic Binary Restenosis (ABR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '1.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '≥13 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-segment Minimum Lumen Diameter (MLD)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.34', 'spread': '0.52', 'groupId': 'OG000'}, {'value': '2.33', 'spread': '0.50', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '≥13 months', 'unitOfMeasure': 'Millimeter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-segment Percent Diameter Stenosis (DS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '16.79', 'spread': '12.36', 'groupId': 'OG000'}, {'value': '18.79', 'spread': '12.42', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': '≥13 months', 'unitOfMeasure': 'percent Diameter stenosis', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Follow-up In-segment Angiographic Binary Restenosis (ABR)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '280', 'groupId': 'OG000'}, {'value': '98', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.1', 'groupId': 'OG000'}, {'value': '3.1', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '≥13 months', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Percent Diameter Stenosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '398', 'groupId': 'OG000'}, {'value': '129', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '64.97', 'spread': '11.90', 'groupId': 'OG000'}, {'value': '64.95', 'spread': '12.01', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'pre procedure', 'unitOfMeasure': 'percent Diameter stenosis', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Percent Diameter Stenosis (%DS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '398', 'groupId': 'OG000'}, {'value': '129', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'title': 'in-stent %DS', 'categories': [{'measurements': [{'value': '8.09', 'spread': '6.31', 'groupId': 'OG000'}, {'value': '8.56', 'spread': '5.78', 'groupId': 'OG001'}]}]}, {'title': 'in-segment %DS', 'categories': [{'measurements': [{'value': '14.40', 'spread': '8.09', 'groupId': 'OG000'}, {'value': '12.46', 'spread': '7.41', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'post procedure on 0 day', 'unitOfMeasure': 'Percent Diameter stenosis', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'SECONDARY', 'title': 'Acute Gain', 'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'OG000'}, {'value': '121', 'groupId': 'OG001'}]}, {'units': 'Target lesions', 'counts': [{'value': '398', 'groupId': 'OG000'}, {'value': '129', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'title': 'In-Stent', 'categories': [{'measurements': [{'value': '1.79', 'spread': '0.44', 'groupId': 'OG000'}, {'value': '1.77', 'spread': '0.43', 'groupId': 'OG001'}]}]}, {'title': 'In-Segment', 'categories': [{'measurements': [{'value': '1.48', 'spread': '0.49', 'groupId': 'OG000'}, {'value': '1.52', 'spread': '0.44', 'groupId': 'OG001'}]}]}, {'title': 'Proximal', 'categories': [{'measurements': [{'value': '2.03', 'spread': '0.53', 'groupId': 'OG000'}, {'value': '2.06', 'spread': '0.49', 'groupId': 'OG001'}]}]}, {'title': 'Distal', 'categories': [{'measurements': [{'value': '1.54', 'spread': '0.54', 'groupId': 'OG000'}, {'value': '1.60', 'spread': '0.51', 'groupId': 'OG001'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'post procedure on 0 day', 'unitOfMeasure': 'Millimeter', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Target lesions', 'denomUnitsSelected': 'Participants', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Patients With Diabetic Disease', 'denoms': [{'units': 'Participants', 'counts': [{'value': '87', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '5.7', 'groupId': 'OG000'}, {'value': '13.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in All Diabetes patients.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Patients Without Diabetic Disease', 'denoms': [{'units': 'Participants', 'counts': [{'value': '272', 'groupId': 'OG000'}, {'value': '91', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.4', 'groupId': 'OG000'}, {'value': '5.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Non Diabetes', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Single Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '332', 'groupId': 'OG000'}, {'value': '113', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.8', 'groupId': 'OG000'}, {'value': '7.1', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with single lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Dual Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '30', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.3', 'groupId': 'OG000'}, {'value': '12.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with dual lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Single Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '339', 'groupId': 'OG000'}, {'value': '114', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.7', 'groupId': 'OG000'}, {'value': '7.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with single vessels treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TVF Rate in Dual Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '24', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.2', 'groupId': 'OG000'}, {'value': '14.3', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with dual vessel treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Patients With Diabetic Disease.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '87', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '3.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in All Diabetes patients.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Patients Without Diabetic Disease', 'denoms': [{'units': 'Participants', 'counts': [{'value': '272', 'groupId': 'OG000'}, {'value': '91', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.2', 'groupId': 'OG000'}, {'value': '1.1', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Non Diabetes', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Single Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '332', 'groupId': 'OG000'}, {'value': '113', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.8', 'groupId': 'OG000'}, {'value': '1.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with single lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Dual Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '30', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.3', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with dual lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Single Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '339', 'groupId': 'OG000'}, {'value': '114', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.8', 'groupId': 'OG000'}, {'value': '1.8', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with single vessels treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'The Composite of ST, All Death, and All MI Rate in Dual Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '24', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.2', 'groupId': 'OG000'}, {'value': '0.0', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with dual vessel treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Patients With Diabetic Disease.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '87', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.4', 'groupId': 'OG000'}, {'value': '3.4', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in All Diabetes patients.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Patients Without Diabetic Disease', 'denoms': [{'units': 'Participants', 'counts': [{'value': '272', 'groupId': 'OG000'}, {'value': '91', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.8', 'groupId': 'OG000'}, {'value': '3.3', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Non Diabetes', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Single Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '332', 'groupId': 'OG000'}, {'value': '113', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.4', 'groupId': 'OG000'}, {'value': '2.7', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with single lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Dual Lesion Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '30', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.00', 'groupId': 'OG000'}, {'value': '12.5', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with dual lesion treated during the index procedure', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Single Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '339', 'groupId': 'OG000'}, {'value': '114', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.4', 'groupId': 'OG000'}, {'value': '2.6', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with single vessels treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'ID-TLR Rate in Dual Vessel Treated Subgroup', 'denoms': [{'units': 'Participants', 'counts': [{'value': '24', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'OG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.0', 'groupId': 'OG000'}, {'value': '14.3', 'groupId': 'OG001'}]}]}], 'paramType': 'NUMBER', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with dual vessel treated during the index procedure.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'The number of participants with angiographic follow up available was analysed.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'FG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '367'}, {'groupId': 'FG001', 'numSubjects': '121'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '360'}, {'groupId': 'FG001', 'numSubjects': '120'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '7'}, {'groupId': 'FG001', 'numSubjects': '1'}]}]}], 'recruitmentDetails': 'A total of 488 patients in the Per-protocol (PP) population for final analysis. First Patient Enrolled on August 18, 2010, Last Patient Enrolled on August 31, 2011 and the Final Database Lock was on September 26, 2013. The total patient enrollment rate was 0.5 patients/site/week based on 489 patients enrolled over 54 weeks at 20 sites.', 'preAssignmentDetails': 'All of the 546 patients, 57 (28:XIENCE;29:CYPHER)were excluded from the Per-protocol (PP) population, leaving a baseline population of 489 patients. Whereas because of patient disposition results in a total of 488 patients in the PP population for final analysis.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '367', 'groupId': 'BG000'}, {'value': '121', 'groupId': 'BG001'}, {'value': '488', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.\n\nXIENCE V EECSS: Patients who will receive this stent.'}, {'id': 'BG001', 'title': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.\n\nCYPHER SELECT PLUS SECSS: Patients who will receive this stent.'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '58.60', 'spread': '10.65', 'groupId': 'BG000'}, {'value': '58.74', 'spread': '9.12', 'groupId': 'BG001'}, {'value': '58.64', 'spread': '10.28', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Age, Customized', 'classes': [{'title': 'Age ≥ 65 years', 'categories': [{'measurements': [{'value': '95', 'groupId': 'BG000'}, {'value': '33', 'groupId': 'BG001'}, {'value': '128', 'groupId': 'BG002'}]}]}, {'title': 'Age < 65 years', 'categories': [{'measurements': [{'value': '272', 'groupId': 'BG000'}, {'value': '88', 'groupId': 'BG001'}, {'value': '360', 'groupId': 'BG002'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '95', 'groupId': 'BG000'}, {'value': '40', 'groupId': 'BG001'}, {'value': '135', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '272', 'groupId': 'BG000'}, {'value': '81', 'groupId': 'BG001'}, {'value': '353', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'Chinese', 'categories': [{'measurements': [{'value': '367', 'groupId': 'BG000'}, {'value': '121', 'groupId': 'BG001'}, {'value': '488', 'groupId': 'BG002'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'China', 'categories': [{'measurements': [{'value': '367', 'groupId': 'BG000'}, {'value': '121', 'groupId': 'BG001'}, {'value': '488', 'groupId': 'BG002'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}], 'populationDescription': 'All of the 546 patients, 57 were excluded from the Per-protocol (PP) population, leaving a baseline population of 489 patients and a total of 488 patients (Based on angiographic follow-up) in the PP population for final analysis. In which 367 were randomized to receive XIENCE V EECSS and 121 to CYPHER SELECT Plus SECSS group.'}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 546}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2010-08'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-07', 'completionDateStruct': {'date': '2014-09', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2016-07-14', 'studyFirstSubmitDate': '2010-08-06', 'resultsFirstSubmitDate': '2016-05-17', 'studyFirstSubmitQcDate': '2010-08-06', 'lastUpdatePostDateStruct': {'date': '2016-08-24', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2016-07-14', 'studyFirstPostDateStruct': {'date': '2010-08-10', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2016-08-24', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2012-10', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'ID-TVF Rate in Patients With Diabetic Disease', 'timeFrame': '24 months', 'description': 'ID-TVF rate in All Diabetes patients.'}, {'measure': 'ID-TVF Rate in Patients Without Diabetic Disease', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Non Diabetes'}, {'measure': 'ID-TVF Rate in Single Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with single lesion treated during the index procedure'}, {'measure': 'ID-TVF Rate in Dual Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with dual lesion treated during the index procedure'}, {'measure': 'ID-TVF Rate in Single Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with single vessels treated during the index procedure.'}, {'measure': 'ID-TVF Rate in Dual Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'ID-TVF rate in Patients with dual vessel treated during the index procedure.'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Patients With Diabetic Disease.', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in All Diabetes patients.'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Patients Without Diabetic Disease', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Non Diabetes'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Single Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with single lesion treated during the index procedure'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Dual Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with dual lesion treated during the index procedure'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Single Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with single vessels treated during the index procedure.'}, {'measure': 'The Composite of ST, All Death, and All MI Rate in Dual Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'The composite of ST, all death, and all MI rate in Patients with dual vessel treated during the index procedure.'}, {'measure': 'ID-TLR Rate in Patients With Diabetic Disease.', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in All Diabetes patients.'}, {'measure': 'ID-TLR Rate in Patients Without Diabetic Disease', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Non Diabetes'}, {'measure': 'ID-TLR Rate in Single Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with single lesion treated during the index procedure'}, {'measure': 'ID-TLR Rate in Dual Lesion Treated Subgroup', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with dual lesion treated during the index procedure'}, {'measure': 'ID-TLR Rate in Single Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with single vessels treated during the index procedure.'}, {'measure': 'ID-TLR Rate in Dual Vessel Treated Subgroup', 'timeFrame': '24 months', 'description': 'Ischemia-driven target lesion revascularization rate in Patients with dual vessel treated during the index procedure.'}], 'primaryOutcomes': [{'measure': 'In-stent Late Loss (LL)', 'timeFrame': '>=13 months', 'description': 'This is the primary angiographic endpoint.\n\nIn-stent LL: The difference between the minimum lumen diameter (MLD) immediately after stent deployment and the MLD at follow-up (within stent)'}, {'measure': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'timeFrame': '12 months', 'description': 'This is the primary efficacy endpoint. Ischemia-driven target vessel failure is defined as the composite of cardiac death, all myocardial infarction (MI) and ischemia-driven target vessel revascularization (ID-TVR).'}, {'measure': 'Incidence of Composite of ST (Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'timeFrame': '12 months', 'description': 'The primary composite safety endpoint was the incidence of the composite of ST (definite and probable), all death (cardiac, vascular and non-cardiovascular), and all MI (including Q-wave and non-Q-wave).'}], 'secondaryOutcomes': [{'measure': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'timeFrame': '30 days', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])'}, {'measure': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'timeFrame': '6 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\]).'}, {'measure': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'timeFrame': '9 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])'}, {'measure': 'Ischemia-driven Target Vessel Failure (ID-TVF)', 'timeFrame': '24 months', 'description': 'Incidence of composite of cardiac death, all MI (including Q-wave and non- Q-wave), and ID target vessel revascularization (ID-TVR) (TLR and non-TLR in the TV \\[PCI and CABG\\])'}, {'measure': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave).', 'timeFrame': '30 days'}, {'measure': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave).', 'timeFrame': '6 months'}, {'measure': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'timeFrame': '9 months'}, {'measure': 'Incidence of Composite of Stent Thrombosis (ST)(Definite and Probable), All Death (Cardiac, Vascular and Non-cardiovascular), and All MI (Including Q-wave and Non-Q-wave)', 'timeFrame': '24 months'}, {'measure': 'Ischemia-driven Target Lesion Revascularization (ID-TLR) (Percutaneous Coronary Intervention [PCI] and Coronary Artery Bypass Graft [CABG])', 'timeFrame': '12 months', 'description': 'The is the major Secondary Efficacy Endpoint.'}, {'measure': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'timeFrame': '30 days', 'description': 'Incidence of composite of cardiac death, MI attributed to the TV and ID-TLR'}, {'measure': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'timeFrame': '6 months', 'description': 'Incidence of composite of cardiac death, MI attributed to the TV and ID-TLR'}, {'measure': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'timeFrame': '9 months', 'description': 'This is one of the Secondary Composite Endpoints.'}, {'measure': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'timeFrame': '12 months', 'description': 'This is one of the Secondary Composite Endpoints.'}, {'measure': 'Ischemia-driven Target Lesion Failure (ID-TLF)', 'timeFrame': '24 months', 'description': 'This is one of the Secondary Composite Endpoints.'}, {'measure': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'timeFrame': '30 days'}, {'measure': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'timeFrame': '6 months'}, {'measure': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'timeFrame': '9 months'}, {'measure': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'timeFrame': '12 months'}, {'measure': 'Incidence of Composite of Cardiac Death and MI (Including Q-wave and Non-Q-wave) Attributed to the Target Vessel (TV)', 'timeFrame': '24 months'}, {'measure': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'timeFrame': '30 days', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].'}, {'measure': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'timeFrame': '6 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].'}, {'measure': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'timeFrame': '9 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].'}, {'measure': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'timeFrame': '12 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].'}, {'measure': 'All Death(Cardiac, Vascular and Non-cardiovascular), All MI, All Revascularization (TLR, TVR, and Non-TVR) (PCI and CABG)', 'timeFrame': '24 months', 'description': 'This is one of the Secondary Composite Endpoint. All death(cardiac, vascular and non-cardiovascular), all MI, all revascularization \\[(target lesion revascularization (TLR), target vessel revascularization (TVR), and non-target lesion revascularization(TVR) \\[Percutaneous coronary intervention (PCI) and Coronary artery bypass graft(CABG)\\].'}, {'measure': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'timeFrame': '30 days'}, {'measure': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'timeFrame': '6 months'}, {'measure': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'timeFrame': '9 months'}, {'measure': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'timeFrame': '12 months'}, {'measure': 'Incidence of Composite of All Death (Cardiac, Vascular and Non-cardiovascular) and All MI', 'timeFrame': '24 months'}, {'measure': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'timeFrame': '30 days'}, {'measure': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'timeFrame': '6 months'}, {'measure': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'timeFrame': '9 months'}, {'measure': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'timeFrame': '12 months'}, {'measure': 'Major Adverse Cardiac Event (Cardiac Death, All MI and TLR)', 'timeFrame': '24 months'}, {'measure': 'All Revascularization (TLR, TVR, and Non-TVR)', 'timeFrame': '30 Days'}, {'measure': 'All Revascularization (TLR, TVR, and Non-TVR)', 'timeFrame': '6 Months'}, {'measure': 'All Revascularization (TLR, TVR, and Non-TVR)', 'timeFrame': '9 Months'}, {'measure': 'All Revascularization (TLR, TVR, and Non-TVR)', 'timeFrame': '12 months'}, {'measure': 'All Revascularization (TLR, TVR, and Non-TVR)', 'timeFrame': '24 months', 'description': 'One of the Secondary Safety Endpoint was all revascularization rates (target lesion, target vessel, non-target lesion, and non-target vessel) (PCI and CABG).'}, {'measure': 'All Death', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.'}, {'measure': 'All Death', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.'}, {'measure': 'All Death', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.'}, {'measure': 'All Death', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.'}, {'measure': 'All Death', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint. All Death includes cardiac, vascular, non-cardiovascular.'}, {'measure': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'All Protocol MI (Including Q-wave or Non-Q-wave)', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Target Vessel Protocol MI (TV-MI)', 'timeFrame': '30 days', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Target Vessel Protocol MI (TV-MI)', 'timeFrame': '6 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Target Vessel Protocol MI (TV-MI)', 'timeFrame': '9 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Target Vessel Protocol MI (TV-MI)', 'timeFrame': '12 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Target Vessel Protocol MI (TV-MI)', 'timeFrame': '24 months', 'description': 'This is one of the secondary safety endpoint.'}, {'measure': 'Major Bleeding Complications', 'timeFrame': '30 days', 'description': 'Secondary safety endpoint.'}, {'measure': 'Major Bleeding Complications', 'timeFrame': '6 months', 'description': 'Secondary safety endpoint.'}, {'measure': 'Major Bleeding Complications', 'timeFrame': '9 months', 'description': 'Secondary safety endpoint.'}, {'measure': 'Major Bleeding Complications', 'timeFrame': '12 months', 'description': 'Secondary safety endpoint.'}, {'measure': 'Major Bleeding Complications', 'timeFrame': '24 months', 'description': 'Secondary safety endpoint.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Acute (<1 day)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Subacute (1 - 30 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Early (0 - 30 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Late (31 - 365 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Very late (366 - 772 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Definite / Probable Stent Thrombosis', 'timeFrame': 'Overall (0 - 772 days)', 'description': 'Stent Thrombosis was adjudicated using Academic Research Consortium (ARC) criteria. Definite Stent Thrombosis defined as angiographic confirmation with at least one of the following: acute onset of ischemic symptoms at rest, new ischemic changes suggestive of acute ischemia, typical rise and fall of cardiac biomarkers; pathological confirmation of ST through either autopsy or tissue examination following thrombectomy. Probable Stent Thrombosis defined as any unexplained death within the first 30 days or, irrespective of the time after the index procedure, any MI related to documented acute ischemia in the territory of the stent without angiographic confirmation.'}, {'measure': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'timeFrame': '30 days'}, {'measure': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'timeFrame': '6 months'}, {'measure': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'timeFrame': '9 months'}, {'measure': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'timeFrame': '12 months'}, {'measure': 'Patient Compliance With Dual Antiplatelet Therapy (DAPT)', 'timeFrame': '24 months'}, {'measure': 'Acute Device Success', 'timeFrame': '< or = 1 day', 'description': 'Per-protocol device success is defined as the achievement of a final in-stent residual diameter stenosis (DS) of \\< 50% by Quantitative Coronary Angiography (QCA), using only the assigned device, and occurring without a device malfunction.'}, {'measure': 'Acute Procedure Success', 'timeFrame': '< or = 1 day', 'description': 'Per-protocol procedure success is defined as the achievement of a final in-stent DS of \\< 50% (by online QCA or visual estimation), using the assigned device and with any adjunctive devices, and occurring without cardiac death, MI (including Q-wave or non-Q-wave), or repeat revascularization of the target lesion during the hospital stay.'}, {'measure': 'Procedure Time', 'timeFrame': 'On day 0, during the procedure.', 'description': 'This is the procedure related endpoint. Procedure time is defined as time between insertion of the first guiding catheter until removal of the last guiding catheter.'}, {'measure': 'Amount of Contrast Used', 'timeFrame': 'On day 0, during the procedure.', 'description': 'Defined as total amount used from insertion of the first guiding catheter until removal of the last guiding catheter.'}, {'measure': 'Fluoroscopy Time', 'timeFrame': 'On day 0, during the procedure.', 'description': 'This is the procedure related endpoint.'}, {'measure': 'XIENCE V EECSS Excellent Overall Performance and Deliverability Using the XIENCE V EECSS Performance Evaluation Questionnaire', 'timeFrame': 'During the procedure', 'description': 'A related secondary performance goal for XIENCE V EECSS is the physician-determined evaluation of acute performance, deliverability, and resource utilization. XIENCE V EECSS acute performance and deliverability were determined using the XIENCE V EECSS Performance Evaluation Questionnaire. Possible responses included strongly agree,moderately agree, agree, moderately disagree, and strongly disagree. Study physicians who enrolled patients into the study were reported for this outcome measure.'}, {'measure': 'Follow-up Late Loss', 'timeFrame': '≥13 months.', 'description': 'This is one of the Secondary Angiographic Endpoint.'}, {'measure': 'Follow-up In-stent Minimum Lumen Diameter (MLD)', 'timeFrame': '≥13 months'}, {'measure': 'Follow-up In-stent Percent Diameter Stenosis (DS)', 'timeFrame': '≥13 months'}, {'measure': 'Follow-up In-stent Angiographic Binary Restenosis (ABR)', 'timeFrame': '≥13 months'}, {'measure': 'Follow-up In-segment Minimum Lumen Diameter (MLD)', 'timeFrame': '≥13 months'}, {'measure': 'Follow-up In-segment Percent Diameter Stenosis (DS)', 'timeFrame': '≥13 months'}, {'measure': 'Follow-up In-segment Angiographic Binary Restenosis (ABR)', 'timeFrame': '≥13 months'}, {'measure': 'Percent Diameter Stenosis', 'timeFrame': 'pre procedure'}, {'measure': 'Percent Diameter Stenosis (%DS)', 'timeFrame': 'post procedure on 0 day'}, {'measure': 'Acute Gain', 'timeFrame': 'post procedure on 0 day'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Drug eluting stents', 'Stents', 'Angioplasty'], 'conditions': ['Coronary Occlusion', 'Thrombosis (Stent Thrombosis)', 'Vascular Disease', 'Myocardial Ischemia', 'Coronary Artery Stenosis', 'Coronary Disease', 'Coronary Artery Disease', 'Coronary Restenosis']}, 'descriptionModule': {'briefSummary': 'This is a prospective, randomized, active-controlled, open label, parallel two-arm, multi-center, post-approval study descriptively comparing the XIENCE V EECSS to the CYPHER SELECT PLUS Sirolimus-Eluting Coronary Stent System (SECSS) ("CYPHER SELECT PLUS") during commercial use in China.', 'detailedDescription': 'Objectives\n\n* Confirm the safety and effectiveness of the XIENCE V EECSS for the treatment of patients in China\n* Evaluate patient compliance with dual antiplatelet therapy (DAPT)\n* Evaluate physician-determined XIENCE V EECSS acute performance, deliverability, and resource utilization'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* General Inclusion Criteria\n\n 1. Patient must be at least 18 years of age\n 2. The patient or patient's legally-authorized representative agrees to participate in this study by signing the Ethics Committee (EC)-approved ICF prior to procedure.\n 3. Patient must agree to undergo all protocol-required follow-ups until the completion of his/her 2-year follow-up.\n 4. Patient must not currently be and must agree not to become a participant in any other clinical trial until completion of his/her 2-year follow-up.\n\nAngiographic Inclusion Criteria\n\n1. Target lesion(s) must be located in a native de novo coronary artery with a visually estimated diameter between ≥ 2.25 and ≤ 4.0 mm.\n2. Target lesion(s) must measure ≤ 28 mm in length by visual estimation.\n3. A maximum of two de novo lesions can be treated, ie,\n\n 1. One lesion in one vessel, OR\n 2. One lesion in each of two vessels, OR\n 3. Two lesions in one vessel\n\nExclusion Criteria:\n\n* General Exclusion Criteria\n\n 1. Pregnant or nursing patients and those who plan pregnancy in the period up to 1 year post index procedure\n 2. Patients with known renal insufficiency or failure (eg, serum creatinine level of \\> 2.5 mg/dL, or patient is on dialysis)\n 3. Patient had an MI within 72 hours and creatine kinase-myocardial band isoenzyme (CK-MB) has not returned to the normal range at the index procedure\n 4. Non-study PCI for lesions in a target vessel (including side branches) has been performed within 1 year prior to the index procedure\n 5. Patient has a planned PCI (staged procedure) within 6 months from the date of the index procedure\n 6. Left ventricular ejection fraction (LVEF) of \\< 30%.\n 7. Any planned surgery necessitating discontinuation of antiplatelet therapy within 1 year\n 8. Patient's current medical condition has a life expectancy of \\< 2 years\n 9. Patient meets contraindications of the IFU\n\nAngiographic Exclusion Criteria\n\n1. Lesion located within an arterial or saphenous vein graft or distal to a diseased arterial or saphenous vein graft\n2. Lesion located in left main coronary artery\n3. Ostial lesion (within 3 mm of the aorta junction, or origin of the left anterior descending or left circumflex arteries)\n4. Involves a bifurcation in which the side branch is ≥ 2 mm in diameter AND the ostium of the side branch is \\> 50% stenosed by visual estimation\n5. Total occluded lesions (TIMI=0)\n6. Restenotic lesions\n7. Thrombus-containing vessel\n8. Extreme angulation (≥ 90º) proximal to or within the lesion\n9. Excessive tortuosity proximal to or within the lesion\n10. Heavy calcification"}, 'identificationModule': {'nctId': 'NCT01178268', 'briefTitle': 'XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)', 'organization': {'class': 'INDUSTRY', 'fullName': 'Abbott Medical Devices'}, 'officialTitle': 'XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)', 'orgStudyIdInfo': {'id': '10-387'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'XIENCE V EECSS', 'description': 'Patients who will receive this stent.', 'interventionNames': ['Device: XIENCE V EECSS']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'CYPHER SELECT PLUS SECSS', 'description': 'Patients who will receive this stent.', 'interventionNames': ['Device: CYPHER SELECT PLUS SECSS']}], 'interventions': [{'name': 'XIENCE V EECSS', 'type': 'DEVICE', 'description': 'Patients who will receive this stent.', 'armGroupLabels': ['XIENCE V EECSS']}, {'name': 'CYPHER SELECT PLUS SECSS', 'type': 'DEVICE', 'description': 'Patients who will receive this stent.', 'armGroupLabels': ['CYPHER SELECT PLUS SECSS']}]}, 'contactsLocationsModule': {'locations': [{'zip': '100037', 'city': 'Beijing', 'country': 'China', 'facility': 'Fu Wai Hospital', 'geoPoint': {'lat': 39.9075, 'lon': 116.39723}}, {'zip': '200122', 'city': 'Shanghai', 'country': 'China', 'facility': 'Authorized Representative in China Guidant International Trading (Shanghai) Co., Ltd.', 'geoPoint': {'lat': 31.22222, 'lon': 121.45806}}], 'overallOfficials': [{'name': 'Gao Runlin, MD, FACC', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Fu Wai Hospital'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Abbott Medical Devices', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}